Whoops: CMS qui­et­ly pares back list of drugs re­quir­ing new re­bates un­der In­fla­tion Re­duc­tion Act

To dis­cour­age rapid drug price in­creas­es, the In­fla­tion Re­duc­tion Act re­quires phar­ma com­pa­nies that raise cer­tain drug prices faster than the rate of in­fla­tion to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER